Open AccessIncreased incidence of serious late adverse events with drug-eluting stents when compared with coronary artery bypass surgery: a cause of concern
Author(s) -
Juan Mieres,
Alfredo E. Rodríguez,
Carlos FernándezPereira,
Diego Ascarrunz-Cattoretti
Publication year - 2020
Publication title -
future cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.392
H-Index - 33
eISSN - 1744-8298
pISSN - 1479-6678
DOI - 10.2217/fca-2020-0033
Subject(s) - medicine , conventional pci , percutaneous coronary intervention , cardiology , myocardial infarction , coronary artery disease , revascularization , adverse effect , artery , randomized controlled trial , coronary artery bypass surgery , bypass surgery , surgery
Percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG) in pre-drug-eluting stents (DESs) era, randomized trials and meta-analysis showed that the extension of coronary artery disease was not associated with a better survival with CABG, and only diabetic patients had an inferior survival with PCI. After the introduction of DES, we would expect a substantial improvement in PCI results compared with CABG, narrowing the gap between both revascularization strategies, However, on the contrary, most randomized studies between DES and CABG showed that rate of recurrences remained and there is an unexpected increased of late serious adverse events including spontaneous myocardial infarction and death. In this review, we try to described each of these problems and find out explanations for these new findings searching for potential solutions.